Literature DB >> 19212104

Measurement of (1-3)-beta-D-glucan derived from different gauze types.

Hajime Kanamori1, Keiji Kanemitsu, Tomomitsu Miyasaka, Koken Ameku, Shiro Endo, Tetsuji Aoyagi, Ken Inden, Masumitsu Hatta, Natsuo Yamamoto, Hiroyuki Kunishima, Hisakazu Yano, Koki Kaku, Yoichi Hirakata, Mitsuo Kaku.   

Abstract

(1-3)-beta-D-glucan (BDG) is a cell-wall polysaccharide component found in most fungi. The measurement of BDG is a useful diagnostic marker for invasive fungal infections. However, it is well known that interfering substances can result in false positive reactions. We encountered a patient who underwent lung transplantation and presented with highly elevated BDG values, despite having no evidence of invasive fungal infection. We therefore hypothesized that elevated BDG values were originated from the gauze products used during surgery. While it is known that gauze products contain BDG, there have been no previous reports to quantitatively correlate amount of gauze usage and BDG levels. In this study, we extracted BDG from various gauze products and measured BDG to better understand the degree of which gauze contributes to elevated BDG values. Six types of commonly used surgical gauze products were selected for our study. Each of the surgical gauze was immersed in sterile, purified water for up to 120 minutes. At set intervals, BDG values in the water extracts were measured. Purified water samples without gauze were used as negative controls (< 4 pg/ml). After 120-minute extraction, BDG levels varied greatly depending on gauze products, ranging from 11.7 pg/ml to 6612 pg/ml. The gauze made of lyocell, which is a fiber produced from wood pulp cellulose, yielded the lowest levels of BDG, and probably would not cause false positive for fungal infections. There is a need for the development of a gauze product that does not contribute to elevated BDG values.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19212104     DOI: 10.1620/tjem.217.117

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  18 in total

1.  Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.

Authors:  J Acosta; M Catalan; A del Palacio-Pérez-Medel; J-C Montejo; J De-La-Cruz-Bértolo; M-D Moragues; J Pontón; M A Finkelman; A del Palacio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-03       Impact factor: 3.267

2.  Determination of β-d-glucan and endotoxin levels in Kampo extracts.

Authors:  Hajime Nakae; Gaku Takahashi; Ryo Sato; Shigehiro Shibata; Shigeatsu Endo
Journal:  Acute Med Surg       Date:  2014-10-01

3.  Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis.

Authors:  Thein Myint; Felicia C Chow; Karen C Bloch; Luke Raymond-Guillen; Thomas E Davis; Patty W Wright; Laila Woc-Colburn; Raed N Khairy; Alan C Street; Tomotaka Yamamoto; Amanda Albers; L Joseph Wheat; Chadi A Hage
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

4.  (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal meningitis associated with contaminated methylprednisolone injections.

Authors:  Anurag N Malani; Bonita Singal; L Joseph Wheat; Ola Al Sous; Theresa A Summons; Michelle M Durkin; April C Pettit
Journal:  J Clin Microbiol       Date:  2014-12-24       Impact factor: 5.948

5.  Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections.

Authors:  O Albert; D Toubas; C Strady; J Cousson; C Delmas; V Vernet; I Villena
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-10       Impact factor: 3.267

6.  Detection of (1→3)-β-d-Glucan in Eumycetoma Patients.

Authors:  Ahmed H Fahal; Malcolm A Finkelman; Yonglong Zhang; Wendy W J van de Sande
Journal:  J Clin Microbiol       Date:  2016-07-20       Impact factor: 5.948

7.  Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.

Authors:  Annie Sulahian; Raphael Porcher; Anne Bergeron; Sophie Touratier; Emmanuel Raffoux; Jean Menotti; Francis Derouin; Patricia Ribaud
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

8.  Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.

Authors:  Tobias Lahmer; Jürgen Held; Sebastian Rasch; Christopher Schnappauf; Analena Beitz; Roland M Schmid; Wolfgang Huber
Journal:  Mycopathologia       Date:  2016-09-12       Impact factor: 2.574

9.  Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.

Authors:  Jürgen Held; Isabelle Kohlberger; Elfriede Rappold; Andrea Busse Grawitz; Georg Häcker
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

10.  β-d-Glucan and Aspergillus Galactomannan assays in the diagnosis of invasive fungal infections.

Authors:  Mahadevan Kumar; M Mugunthan
Journal:  Med J Armed Forces India       Date:  2017-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.